GlobeNewswire
-
March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB-105 CD5 CAR-T Cell Therapy at ASH 2025 Annual Meeting
08/12/2025 -
Wake Radiology’s Dr. Monica Reddy Recognized as a National Leader on the Radiology Business Forty Under 40 List
08/12/2025 -
SafeSpace Global (SSGC) Announces Strategic Partnership With 911inform to Transform School Safety Across America
08/12/2025 -
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
08/12/2025 -
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
08/12/2025 -
UMC Utrecht Selects PathAI’s AISight® Dx to Accelerate Research on AI Pathology Algorithms
08/12/2025 -
Sharecare partners with CLEAR to power trusted digital identity for AskMD, enable secure access to personalized clinical care and benefits
08/12/2025 -
Neurona Therapeutics Presents New Long-Term Clinical Data from NRTX-1001 Cell Therapy Trials at 2025 Annual Meeting of the American Epilepsy Society
08/12/2025 -
HealthLynked Appoints Duncan McGillivray as Chief Operating Officer to Accelerate National Expansion and Nasdaq Uplisting Strategy
08/12/2025 -
4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference
08/12/2025 -
SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management
08/12/2025 -
Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
08/12/2025 -
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia
08/12/2025 -
Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf CAR T-cell Programs
08/12/2025 -
Praxis AES Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies
08/12/2025 -
Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenström Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
08/12/2025 -
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees
08/12/2025 -
Solid Biosciences to Showcase Proprietary Next-Generation Capsid AAV-SLB101 and Cardiac Gene Therapy Pipeline at the 22nd Global CardioVascular Clinical Trialists (CVCT) Forum
08/12/2025 -
Soleo Health Appoints Jody Thompson as New Senior Vice President of Business Development, Rare Disease
08/12/2025
Pages